Clinical research

Clinical Monitoring

Experienced clinical research associates who safeguard your participants and the integrity of your data, delivering risk-based monitoring to the standard expected in both local and global multinational studies.

Monitoring provides the sponsor with assurance that a study is being conducted as intended: that participants have given valid consent, that their safety is protected, that the protocol is observed, and that the database faithfully reflects what occurred at the site. Our monitors act as your representatives at every site.

Our clinical research associates are trained in ICH E6 (R3) and experienced in both local studies and global multinational programmes conducted under sponsors’ own procedures. They understand the protocol, they know the investigators, and they anticipate what an auditor or inspector will examine.

We apply a risk-based approach. On-site visits, remote review and centralised monitoring of data in Insight EDC are combined within one plan, concentrating effort on critical data and processes and detecting deficiencies early rather than at study close.

Clinical monitoring
What we provide

Monitoring calibrated to the risk profile of your study

Our clinical research associates integrate on-site, remote and centralised monitoring within a single risk-based strategy, directing oversight to the data and processes that matter most.

  • Risk assessment and monitoring plan

    A documented assessment of the critical data and processes in your study, translated into a monitoring plan that defines the frequency, depth and modality of every visit.

  • Site qualification visits

    Pre-study visits confirming that each site has the patient population, personnel, facilities and systems the protocol demands.

  • Site initiation visits

    Comprehensive training of the site team on the protocol, GCP, safety reporting, investigational product handling and Insight EDC before recruitment opens.

  • Routine on-site monitoring

    Scheduled visits to verify source data, review consent and essential documents, confirm protocol compliance and support the investigator team.

  • Remote and centralised monitoring

    Ongoing review of data in Insight EDC between visits to detect trends, outliers, missing data and emerging site risks without waiting for the next visit.

  • Source data verification and review

    Targeted verification of critical data against medical records, and evaluation of source documentation for quality, completeness and consistency.

  • Safety oversight

    Assurance that adverse events and serious adverse events are identified, documented and reported within regulatory timelines.

  • Investigational product accountability

    Verification of storage conditions, temperature records, dispensing, returns and reconciliation of investigational product at every site.

  • Co-monitoring and oversight visits

    Joint visits with sponsor representatives, and independent oversight of monitoring conducted by other providers when a second perspective is required.

  • Close-out visits

    Final reconciliation of data, documentation and investigational product, and formal closure of each site.

  • Audit and inspection readiness

    Preparation of sites ahead of sponsor audits and authority inspections, and support in addressing any resulting observations.

Our methodology

A disciplined monitoring cycle at every site

  1. 01

    Plan

    We evaluate the risks inherent in the study and agree the monitoring strategy with you before the first site is activated.

  2. 02

    Prepare

    Ahead of each visit, the monitor reviews the site’s data, outstanding queries, deviations and prior findings, and shares a structured agenda with the site.

  3. 03

    Visit

    On site or remotely, the monitor verifies critical data, reviews documentation and consent, inspects investigational product and meets the investigator.

  4. 04

    Report

    A comprehensive visit report and follow-up letter document each finding, the corrective action agreed and the responsible party.

  5. 05

    Resolve

    Every action is tracked through to closure. Any matter affecting participant safety or data integrity is escalated to you immediately.

  6. 06

    Adapt

    Monitoring intensity evolves with the study, increasing at sites showing emerging risk and reducing where quality is consistently high.

What you receive

Complete visibility across every site

Our reporting keeps you continuously informed of site performance and maintains a state of readiness for any audit or inspection.

  • 01

    Monitoring plan

    The agreed strategy for each site and each visit type, maintained throughout the study.

  • 02

    Visit reports and follow-up letters

    Issued promptly after every visit, setting out findings, actions and responsibilities.

  • 03

    Issue and deviation tracking

    A current log of outstanding actions and protocol deviations across all sites, with their status.

  • 04

    Site performance summaries

    Recruitment, data entry, query and safety indicators for each site within your regular progress reports.

  • 05

    Inspection-ready files

    Investigator site files and the trial master file kept complete and current from the first visit to the last.

Standards

Monitoring to local and global expectations

Our monitors apply the same rigour whether the study is conducted locally or forms part of a global multinational programme.

  • 01

    ICH E6 (R3) Good Clinical Practice

    Including its risk-based approach to quality management and monitoring.

  • 02

    Egyptian Drug Authority requirements

    National expectations for clinical trial monitoring, safety reporting and inspections.

  • 03

    Sponsor SOPs and global monitoring plans

    In multinational studies, we operate within your procedures and systems alongside our own.

  • 04

    Declaration of Helsinki

    The rights, safety and wellbeing of participants take precedence at every visit.

Let’s discuss your next project

Share your scope, timeline and budget. We will come back with a clear plan, defined milestones and a named project lead who is accountable for delivering on time, within budget and to the quality you expect.

  • Defined scope
  • Agreed milestones
  • On time
  • Within budget
Start your project